Back to Search
Start Over
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics.
- Source :
- Psoriasis: Targets & Therapy; Jun2021, Vol. 11, p83-97, 15p
- Publication Year :
- 2021
-
Abstract
- Psoriasis is a common chronic inflammatory skin disease associated with several comorbidities and reduced quality of life. In the past decades, highly effective targeted therapies have led to breakthroughs in the management of psoriasis, providing important insights into the pathogenesis. This article reviews the current concepts of the pathophysiological pathways and the recent progress in antipsoriatic therapeutics, highlighting key targets, signaling pathways and clinical effects in psoriasis. [ABSTRACT FROM AUTHOR]
- Subjects :
- PSORIASIS
QUALITY of life
THERAPEUTICS
SKIN diseases
PSORIATIC arthritis
COMORBIDITY
Subjects
Details
- Language :
- English
- ISSN :
- 2230326X
- Volume :
- 11
- Database :
- Complementary Index
- Journal :
- Psoriasis: Targets & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 151882696
- Full Text :
- https://doi.org/10.2147/PTT.S294173